FOLH1 and neoplasm: At present, high tumor uptake of [68Ga]Ga-PSMA-11, [18F]DCFPyL, or [18F]PSMA-1007 on positron emission tomography (PET) imaging is mandatory for PSMA radioligand therapy [26–30].